Stockreport

Praxis gains after mid-stage data for epilepsy candidate [Seeking Alpha]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF 100% complete response in a mid-stage trial for patients with photo paroxysmal response, a characteristic of epilepsy. Following an analysis of eight patients in its P [Read more]